http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011334928-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32442a1761c50204a02025c8ed897f52
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
filingDate 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e312a552f80f48ff6844d135803240e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21818c88ccef1fe1fa9f65195e5ac2a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dde2ebfe1c00f51ebcc4167c992527f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_234640437d3daeb49cae07634027f0c2
publicationDate 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2011334928-A1
titleOfInvention Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
abstract The present invention relates to a pure polymorph of Nor-UDCA or Bis-nor-UDCA, or of a pharmaceutically acceptable salt thereof. The invention further provides a pharmaceutical composition comprising the polymorph of the invention, and a method for preparing the polymorph. The invention includes the pharmaceutical use of the polymorph or of the pharmaceutical composition of the invention.
priorityDate 2010-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447656291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426108588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450145743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6440874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21879760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID192254
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID556499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415870595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9929677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502692
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5205

Total number of triples: 53.